These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2611648)

  • 1. A magnetic resonance imaging contrast agent differentiates between the vascular properties of fetal striatal tissue transplants and gliomas in rat brain in vivo.
    Norman AB; Thomas SR; Pratt RG; Samaratunga RC; Sanberg PR
    Brain Res; 1989 Nov; 503(1):156-9. PubMed ID: 2611648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective enhancement of experimental rat brain tumors with Gd-TPPS.
    Bockhorst K; Els T; Hoehn-Berlage M
    J Magn Reson Imaging; 1994; 4(3):451-6. PubMed ID: 8061446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging of rat brain following in vivo disruption of the cerebral vasculature.
    Norman AB; Bertram KJ; Thomas SR; Pratt RG; Samaratunga RC; Sanberg PR
    Brain Res Bull; 1991 Apr; 26(4):593-7. PubMed ID: 1907878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR imaging of rat brain glioma: Gd-DTPA versus Gd-DOTA.
    Runge VM; Jacobson S; Wood ML; Kaufman D; Adelman LS
    Radiology; 1988 Mar; 166(3):835-8. PubMed ID: 3401296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging of experimental rat brain tumors: histopathological evaluation.
    Baba T; Moriguchi M; Natori Y; Katsuki C; Inoue T; Fukui M
    Surg Neurol; 1990 Dec; 34(6):378-82. PubMed ID: 2244301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental trials with Gd(DO3A)--a nonionic magnetic resonance contrast agent.
    Runge VM; Kaufman DM; Wood ML; Adelman LS; Jacobson S
    Int J Rad Appl Instrum B; 1989; 16(6):561-7. PubMed ID: 2606711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of nonionic low-osmolar gadodiamide injection in animals with intracranial mass lesions.
    Carvlin MJ; Rajan SS; Rosa L; Muraki AS; Francisco J; Rocklage SM
    J Magn Reson Imaging; 1992; 2(1):19-24. PubMed ID: 1623277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gd-DTPA administered MR imaging of intracranial mass lesions: a comparison with CT and precontrast MR.
    Mihara F; Hirakata R; Hasuo K; Yasumori K; Yoshida K; Kuroiwa T; Masuda K; Fukui M
    Radiat Med; 1989; 7(5):227-35. PubMed ID: 2629036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging of rat brain following kainic acid-induced lesions and fetal striatal tissue transplants.
    Norman AB; Thomas SR; Pratt RG; Samaratunga RC; Sanberg PR
    Brain Res; 1989 Mar; 483(1):188-91. PubMed ID: 2706507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI characterization of 9L-glioma in rat brain at 4.7 Tesla.
    Rajan SS; Rosa L; Francisco J; Muraki A; Carvlin M; Tuturea E
    Magn Reson Imaging; 1990; 8(2):185-90. PubMed ID: 2338899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of T1 time course changes and tissue-blood ratios after Gd-DTPA administration in brain tumors.
    Yoshida K; Furuse M; Kaneoke Y; Saso K; Inao S; Motegi Y; Ichihara K; Izawa A
    Magn Reson Imaging; 1989; 7(1):9-15. PubMed ID: 2918823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyke Award Paper. Kinetics of pathologic blood-brain-barrier permeability in an astrocytic glioma using contrast-enhanced MR.
    Schmiedl UP; Kenney J; Maravilla KR
    AJNR Am J Neuroradiol; 1992; 13(1):5-14. PubMed ID: 1595491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative magnetic resonance imaging of rat brain tumors: in vivo NMR relaxometry for the discrimination of normal and pathological tissues.
    Hoehn-Berlage M; Bockhorst K
    Technol Health Care; 1994 Dec; 2(4):247-54. PubMed ID: 7842309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gadolinium-DTPA-enhanced and digitally subtracted magnetic resonance imaging of estrogen-induced pituitary lesions in rats: correlation with pituitary anatomy.
    van Nesselrooij JH; Szeverenyi NM; Tillapaugh-Fay GM; Hendriksen FG
    Magn Reson Imaging; 1990; 8(5):525-33. PubMed ID: 2082122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gd-DTPA-enhanced MR imaging in pediatric patients after brain tumor resection.
    Bird CR; Drayer BP; Medina M; Rekate HL; Flom RA; Hodak JA
    Radiology; 1988 Oct; 169(1):123-6. PubMed ID: 3420247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delineation of gliomas with magnetic resonance imaging using Gd-DTPA in comparison with computed tomography and positron emission tomography.
    Tovi M; Lilja A; Bergström M; Ericsson A; Bergström K; Hartman M
    Acta Radiol; 1990 Sep; 31(5):417-29. PubMed ID: 2261284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mn-metalloporphyrin conjugated with Gd-DTPA (Gd-ATN10): tumor enhancement agent for magnetic resonance imaging.
    Matsumura A; Shibata Y; Yamamoto T; Nakagawa K; Yasuda S; Nakajima S; Sakata I; Yoshizawa T; Nose T
    Neurol Med Chir (Tokyo); 1997 Apr; 37(4):327-31. PubMed ID: 9136556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Brain and spinal tumors: magnetic resonance imaging using gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA)].
    Fang YX
    Zhonghua Yi Xue Za Zhi; 1989 Jun; 69(6):305-7, 22. PubMed ID: 2804747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Gd-DTPA-induced signal enhancements in rat brain C6 glioma among different pulse sequences in 3-Tesla magnetic resonance imaging.
    Sato H; Enmi J; Teramoto N; Hayashi T; Yamamoto A; Tsuji T; Naito H; Iida H
    Acta Radiol; 2008 Mar; 49(2):172-9. PubMed ID: 18300142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioblastoma multiforme: MR imaging at 1.5 and 9.4 T after injection of polylysine-DTPA-Gd in rats.
    Kornguth S; Anderson M; Turski P; Sorenson J; Robins HI; Cohen J; Rappe A; Markley J
    AJNR Am J Neuroradiol; 1990; 11(2):313-8. PubMed ID: 2156411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.